JP2003506335A - マンノースレセプターリガンドを調製するためのキナ酸、シキミ酸およびそれらの誘導体の使用 - Google Patents

マンノースレセプターリガンドを調製するためのキナ酸、シキミ酸およびそれらの誘導体の使用

Info

Publication number
JP2003506335A
JP2003506335A JP2001513979A JP2001513979A JP2003506335A JP 2003506335 A JP2003506335 A JP 2003506335A JP 2001513979 A JP2001513979 A JP 2001513979A JP 2001513979 A JP2001513979 A JP 2001513979A JP 2003506335 A JP2003506335 A JP 2003506335A
Authority
JP
Japan
Prior art keywords
compound
group
receptor
acid
ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2001513979A
Other languages
English (en)
Japanese (ja)
Inventor
シリル グランジャン
オレグ メルニー
ヘレン グラス−マッセ
ゲルヒルト アンギャロシ
コリーヌ ロメン
クラウド オウリオルト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of JP2003506335A publication Critical patent/JP2003506335A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2001513979A 1999-07-30 2000-07-28 マンノースレセプターリガンドを調製するためのキナ酸、シキミ酸およびそれらの誘導体の使用 Withdrawn JP2003506335A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR99/09928 1999-07-30
FR9909928A FR2797441B1 (fr) 1999-07-30 1999-07-30 Derives des cyclohexane, cyclohexene, cyclohexadiene et benzene pour la preparation de ligands du recepteur du mannose
PCT/FR2000/002194 WO2001009173A2 (fr) 1999-07-30 2000-07-28 Utilisation des acides quinique, shikimique et de leurs derives pour la preparation de ligands du recepteur du mannose

Publications (1)

Publication Number Publication Date
JP2003506335A true JP2003506335A (ja) 2003-02-18

Family

ID=9548718

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001513979A Withdrawn JP2003506335A (ja) 1999-07-30 2000-07-28 マンノースレセプターリガンドを調製するためのキナ酸、シキミ酸およびそれらの誘導体の使用

Country Status (6)

Country Link
EP (1) EP1200462A2 (fr)
JP (1) JP2003506335A (fr)
AU (1) AU6846900A (fr)
CA (1) CA2388663A1 (fr)
FR (1) FR2797441B1 (fr)
WO (1) WO2001009173A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014506570A (ja) * 2011-02-09 2014-03-17 オーガノバランス ゲーエムベーハー 皮膚状態の治療に使用するためのペプチド

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101245068A (zh) 2007-02-14 2008-08-20 浙江医药股份有限公司新昌制药厂 结晶型态的恩替卡韦及其制备方法和其药物组合物及用途
CN101284799B (zh) 2007-03-23 2013-04-03 浙江医药股份有限公司新昌制药厂 咖啡酰奎宁酸含氮衍生物及其制备方法和其药物组合物及用途
CN101397333A (zh) 2007-09-27 2009-04-01 浙江医药股份有限公司新昌制药厂 去羟基万古霉素及其制备方法、和其药物组合物及其用途
CN101828693B (zh) 2009-03-09 2013-01-02 浙江医药股份有限公司新昌制药厂 制备低粘度高流动性类胡萝卜素油悬浮液的方法及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5432260A (en) * 1991-05-03 1995-07-11 Washington University High affinity mannose receptor ligands
EP0738154A1 (fr) * 1993-08-06 1996-10-23 Abbott Laboratories Analogues de lhrh a extremite n-terminale modifiee

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014506570A (ja) * 2011-02-09 2014-03-17 オーガノバランス ゲーエムベーハー 皮膚状態の治療に使用するためのペプチド

Also Published As

Publication number Publication date
WO2001009173A3 (fr) 2001-08-16
FR2797441B1 (fr) 2001-10-12
FR2797441A1 (fr) 2001-02-16
AU6846900A (en) 2001-02-19
CA2388663A1 (fr) 2001-02-08
WO2001009173A2 (fr) 2001-02-08
EP1200462A2 (fr) 2002-05-02

Similar Documents

Publication Publication Date Title
Grigalevicius et al. Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines
FI94419B (fi) Menetelmä terapeuttisesti käyttökelpoisen membraaniankkuri-vaikuttava-ainekonjugaatin valmistamiseksi
Foillard et al. 1-Ethoxyethylidene, a new group for the stepwise SPPS of aminooxyacetic acid containing peptides
US6552167B1 (en) Polyamide chains of precise length
Yang et al. Sugar-assisted ligation in glycoprotein synthesis
EP0535155B1 (fr) Banques de peptides modifies resistant a la protease
JP6368304B2 (ja) 生物活性化合物の送達に有用な機能性リポソーム
EA003790B1 (ru) Соединение сдлс и способ его измерения
JP6880073B2 (ja) マルチアーム重合標的抗がんコンジュゲート
CN113292635B (zh) 靶向cd47的多肽及其应用
US9012594B2 (en) Catalyst and byproduct-free native chemical ligation using cyclic thioester precursors
US6677164B1 (en) Multivalent polymers, processes for their preparation, and their use for preparing biologically active compounds
JP2003506335A (ja) マンノースレセプターリガンドを調製するためのキナ酸、シキミ酸およびそれらの誘導体の使用
JP5072164B2 (ja) ペプチドと親油性ベクターとを溶液中で結合するための方法およびその使用
JPH08510210A (ja) ポリオキシム化合物及びそれらの調整
Inman et al. Synthesis of N. alpha.-(tert-butoxycarbonyl)-N. epsilon.-[N-(bromoacetyl)-. beta.-alanyl]-L-lysine: Its use in peptide synthesis for placing a bromoacetyl cross-linking function at any desired sequence position
CN109311910B (zh) 他克莫司偶联物、其组合物、及其用途
JP2007527864A (ja) 自然に起こる化学的連結による、多官能化ペプチドおよび／またはタンパク質の調製方法
US11723985B2 (en) Protein delivery to membranes
Ma et al. Chemical Synthesis of Peptides and Proteins Bearing Base‐Labile Post‐Translational Modifications: Evolution of the Methods in Four Decades
CN116947969A (zh) 一种靶向pd-l1的多肽、制备方法，组装形成纳米球及应用
WO2024141787A2 (fr) Plateforme à base de billes d'hydrogel aux fins du criblage à haut débit de peptides immunomodulateurs et de peptides de conception pour la reprogrammation de cellules dendritiques/macrophages
Wang Biomaterials from a modular peptide scaffold
JP2023163455A (ja) 反応性官能基を有するポリマー
CN115093458A (zh) 一种酸激活穿膜多肽载体及其应用

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20071002